Thyroid Hormone Synthesis Inhibitor
31 drugs across 14 manufacturers|31 Generic,0 Brand
The Thyroid Hormone Synthesis Inhibitor class contains 31 NDCs from 14 manufacturers (31 generic, 0 brand), at an average NADAC of $0.14 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
31
31G / 0B
Manufacturers
14
Avg $0.1382/unit
Avg 7d Change
-2.44%
Across 30 drugs with changes
7d Activity
of 31 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
14 manufacturers producing drugs in this therapeutic class
and 2 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Chartwell RX LLC manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Methimazole market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Thyroid Hormone Synthesis Inhibitor class?
The Thyroid Hormone Synthesis Inhibitor class contains 31 NDCs from 14 manufacturers — 31 generic and 0 brand products.
What is the average price of Thyroid Hormone Synthesis Inhibitor drugs?
The average NADAC for the Thyroid Hormone Synthesis Inhibitor class is $0.1382 per unit across 31 NDCs.
Which manufacturers make Thyroid Hormone Synthesis Inhibitor drugs?
14 manufacturers make drugs in the Thyroid Hormone Synthesis Inhibitor class. Ranked by number of NDCs, the largest are Chartwell RX LLC (5), Macleods Pharmaceuticals Limited (3), American Health Packaging (3), Strides Pharma Inc. (3), Endo USA Inc. (2).
How has Thyroid Hormone Synthesis Inhibitor pricing changed recently?
Over the past 7 days, 0 NDCs in this class rose and 30 fell, with a class-wide average change of -2.4%.